Match tier
Institution-verified
Presence
Current · Arkansas
Last published
2026
Sources
Institutional record
Refreshed
2026-10-07
A
Anushareddy Muddasani
Sourced from institutional research profiles (UAMS TRI or ARA).
Assistant Professor
Also affiliated: Western Michigan University (2019)
1 h-index
19 pubs
7 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Anushareddy Muddasani's research focuses on clinical outcomes and treatment effectiveness in various patient populations. Recent work includes an analysis of CAR T-cell therapy and bispecific antibody therapy in patients with relapsed/refractory multiple myeloma, considering the impact of renal impairment. Muddasani has also investigated the outcomes and toxicity of CAR T-cell therapy in patients with renal impairment, as well as the safety and effectiveness of bispecific antibody therapy across different levels of kidney function. Further research areas include the impact of dementia on outcomes for patients hospitalized with urinary tract infections and the relationship between intranasal corticosteroid use and the risk of invasive fungal sinusitis in specific patient groups. Muddasani has also contributed to case reports, including a study on gastric linitis plastica presenting as large bowel obstruction.
Metrics
- h-index: 1
- Publications: 19
- Citations: 7
Positions
-
University of Arkansas for Medical Sciences publications 2024–2026ORCID
-
Assistant Professor publications 2024–2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma (2026)
-
MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma (2026)
-
POSTER: MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma (2026)
-
POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma (2026)
-
Immune effector cell associated hematotoxicity (ICAHT) with BCMA CAR T cell therapy in the earlier lines (2026)
-
Impact of Dementia on Outcomes in Patients Hospitalized with Urinary Tract Infections (2026)
-
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis (2026)
-
Metabolic health and risk of early-onset cancers in obese young adults: Real-world insights from a large cohort study. (2026)
-
Heterogeneity of cancer prevalence in young adults in the post–COVID-19 era: A multicenter real-world analysis. (2026)
-
Influence of genomic and clinical high-risk features on outcomes after BCMA-directed bispecific antibody therapy in relapsed/refractory multiple myeloma. (2026)
-
Association of prior SARS-CoV-2 infection with advanced cancer presentation in newly diagnosed solid tumors: A real-world data analysis. (2026)
-
Genomic Biomarkers for First-Line Treatment Selection in Metastatic Pancreatic Ductal Adenocarcinoma: A Narrative Review (2026)
-
Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report (2026)
-
Comparing Guillain-Barré syndrome outcomes between rural and urban hospitals in the United States: A retrospective cohort study (2025)
-
Inflammatory Pseudotumor of the Skull Base Mimicking Neoplasm: A Rare Case of Trigeminal Neuropathy (2025)
Collaboration Network
Top Collaborators
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
7 shared publications
In database
- Influence of genomic and clinical high-risk features on outcomes after BCMA-directed bispecific antibody therapy in relapsed/refractory multiple myeloma.
- Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis
- Immune effector cell associated hematotoxicity (ICAHT) with BCMA CAR T cell therapy in the earlier lines
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- POSTER: MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
Showing 5 of 7 shared publications
Anudeep Surendranath
National Park College (US)
4 shared publications
- The Effect of Sickle Cell Disease on Seizure-Related Hospitalizations: An Analysis of the Nationwide Inpatient Sample 2021
- Inflammatory Pseudotumor of the Skull Base Mimicking Neoplasm: A Rare Case of Trigeminal Neuropathy
- Comparing Guillain-Barré syndrome outcomes between rural and urban hospitals in the United States: A retrospective cohort study
- Impact of Dementia on Outcomes in Patients Hospitalized with Urinary Tract Infections
Maurizio Zangari
University of Arkansas for Medical Sciences
4 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- POSTER: MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
Carolina Schinke
University of Arkansas for Medical Sciences
4 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- POSTER: MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
N. S. Kumar
University of Arkansas for Medical Sciences
2 shared publications
In database
- Association of prior SARS-CoV-2 infection with advanced cancer presentation in newly diagnosed solid tumors: A real-world data analysis.
- Heterogeneity of cancer prevalence in young adults in the post–COVID-19 era: A multicenter real-world analysis.
Shi-Ming Tu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Heterogeneity of cancer prevalence in young adults in the post–COVID-19 era: A multicenter real-world analysis.
- Metabolic health and risk of early-onset cancers in obese young adults: Real-world insights from a large cohort study.
Frits van Rhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis
- Immune effector cell associated hematotoxicity (ICAHT) with BCMA CAR T cell therapy in the earlier lines
Carolina Schinke
University of Arkansas for Medical Sciences
2 shared publications
In database
- Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis
- Immune effector cell associated hematotoxicity (ICAHT) with BCMA CAR T cell therapy in the earlier lines
Frits Vanrhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
Frits van Rhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- POSTER: MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
- MM-224: Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma
Rachel Hendrix
University of Arkansas for Medical Sciences
1 shared publication
In database
- Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients
Milan Bimali
University of Arkansas for Medical Sciences
1 shared publication
In database
- Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients
Asis Shrestha
University of Arkansas for Medical Sciences
1 shared publication
In database
- Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients
Bhavesh Mohan Lal
University of Arkansas for Medical Sciences
1 shared publication
In database
- Incidence and impact of incidental pulmonary embolism in solid cancer patients.
Rangaswamy Govindarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Incidence and impact of incidental pulmonary embolism in solid cancer patients.
Similar Researchers
Based on overlapping research topics
Rahaf Omaish
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Acute Kidney Injury
Pharmacological Effects and Toxicity Studies
Jaskirat Sethi
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Abedalrahman Almashayekh
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Acute Kidney Injury
Pharmacological Effects and Toxicity Studies
Tanvi Harishbhai Patel
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Cesar Gentille
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Sarenthia M. Epps
University of Arkansas for Medical Sciences
Acute Kidney Injury
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research